Late-Breaking Research

Witness First-Time Presentations of Major Clinical Trials and Impactful Science Research

Get a front-row seat to the latest breakthroughs that will change your practice and redefine patient care globally.

TRI-QOL: Defining an Optimal Result of TTVI Suzanne Arnold	PASCAL M-TEER: Early US Commercial Experience from the TVT Registry Santiago Garcia
EARLY TAVR: Guideline-Directed Indications and Consequences of Delayed AVR Allan Schwartz	TRISCEND II: 1-Year Echocardiographic Outcomes of TTVR vs. Medical Therapy Paul Grayburn
Navitor: Early US Commercial Experience from the TVT Registry Santiago Garcia	TRILUMINATE: Disease Progression and Crossover Outcomes Matthew Price
FOLDAX Mitral Valve Replacement: 1-Year Outcomes Isaac George	INTREPID TMVR: 2-Year Outcomes from the EARLY Feasibility Study Gilbert Tang
Prognostic Impact of T-TEER In the BRONX Valve and TRIPSA Registries Julio Echarte Morales	DETECT AS: Impact of Electronic Provider Notification on Disparities in AVR Sammy Elmariah
Global and Regional Burden of Degenerative Mitral Valve Disease (from the Global Burden of Disease Study) Guido Ascione	Redo TAVR and TAVR Explant: Current Trends and Outcomes Shinichi Fukuhara